Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.87M | $6.26M | $7.20M | $259K | $22.0K | $14.0K | $442K | $420K | $819K |
| Revenue growth | — | 6.6% | 15.1% | -96.4% | -91.5% | -36.4% | 3057.1% | -5.0% | 95.0% |
| Gross profit | $1.71M | $2.05M | -$1.65M | -$1.91M | -$1.54M | -$147K | $412K | $378K | $756K |
| Gross margin | 29.0% | 32.8% | -22.9% | -738.6% | -6990.9% | -1050.0% | 93.2% | 90.0% | 92.3% |
| Operating income | -$17.8M | -$31.2M | -$57.7M | -$35.4M | -$29.3M | -$27.0M | -$78.1M | -$11.2M | -$21.1M |
| Operating margin | -302.6% | -498.0% | -801.9% | -13668.3% | -133027.3% | -192578.6% | -17674.0% | -2676.9% | -2581.6% |
| Net income | -$17.8M | -$30.8M | -$57.0M | -$36.0M | -$25.1M | -$26.9M | -$70.6M | -$16.6M | -$17.2M |
| Net margin | -302.6% | -492.8% | -791.2% | -13917.0% | -113954.5% | -191892.9% | -15966.5% | -3962.6% | -2098.0% |
| EPS (diluted) | -$2.35 | -$3.34 | -$108.28 | -$21.22 | -$248.22 | -$25.98 | — | — | — |
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$5.52M | -$18.5M | -$33.2M | -$28.3M | -$27.6M | -$22.6M | -$20.6M | -$9.27M | -$8.30M |
| Capital expenditures | $547K | $582K | $268K | $67.0K | $265K | $17.0K | $76.0K | $67.0K | $17.0K |
| Free cash flow | -$6.07M | -$19.1M | -$33.4M | -$28.4M | -$27.9M | -$22.6M | -$20.7M | -$9.34M | -$8.31M |
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $8.24M | $64.3M | $14.6M | $23.9M | $15.0M | $15.9M | $3.56M | $2.87M | $88.0K |
| Total assets | $11.3M | $74.0M | $44.1M | $33.4M | $21.0M | $16.8M | $30.7M | $27.8M | $15.9M |
| Total liabilities | $18.9M | $7.33M | $10.9M | $12.3M | $7.37M | $7.58M | $9.54M | $16.0M | $9.21M |
| Long-term debt | — | $850K | $558K | — | — | — | — | — | $3.08M |
| Shareholders' equity | -$7.62M | $66.7M | $33.1M | $21.1M | $13.7M | $9.26M | $21.2M | $11.8M | $7.05M |
| Retained earnings | -$29.4M | -$60.2M | -$117M | -$153M | -$178M | -$205M | -$276M | -$292M | -$310M |
| Shares (wtd avg diluted) | 7.89M | 12.7M | 551K | 3.19B | 101K | 1.03M | 550K | 172K | 1.08M |
Every figure is extracted from Catheter Precision, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.